16:20 EST Agios Pharmaceuticals (AGIO) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGIO:
- Agios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating
- Agios Pharmaceuticals reports Q4 revenue $20.0M, consensus $12.06M
- JPMorgan large/SMid cap biotech analysts hold analyst/industry conference call
- AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Agios Expands Rare-Disease Pipeline With New Phase 1b PKU Study of AG-181